NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma
Ana M. Molina, Johannes C. van der Mijn, Paul J. Christos, John Wright, Charlene Thomas, Janice P. Dutcher, David M. Nanus, Scott T. Tagawa, Lorraine J. Gudas
Topics & Concepts
IsotretinoinVorinostatRenal cell carcinomaRetinoic acidMedicineTretinoinInternal medicineOncologyCancer researchPharmacologyDermatologyChemistryBiochemistryHistoneHistone deacetylaseAcneGeneHistone Deacetylase Inhibitors ResearchRetinoids in leukemia and cellular processesProtein Degradation and Inhibitors